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Abstract: In this study, the BOX-PCR fingerprinting technique was evaluated for the discrimination of clinical
Pseudomonas aeruginosa isolates. All isolates were typeable and nearly half showed unique banding patterns.
According to our results, BOX-PCR fingerprinting is applicable for typing of Pseudomonas aeruginosa isolates
and can be considered a useful complementary tool for epidemiological studies of members of this genus.
(Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 4, pp. 734–738)
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Introduction
Pseudomonas aeruginosa is an organism commonly
occurring in soil, water, plants, animals and hu-
mans. Normally, Pseudomonas aeruginosa resides
in the intestinal tract of a rather small percentage
of healthy individuals. It is found sporadically in
moist areas of the human skin and in the saliva. It
can multiply in almost any moist environment and
has minimal nutritional requirements. Moreover,
it is tolerant to a wide variety of physical condi-
tions. Consequently, the microorganism can be
found frequently in the hospital environment and
home reservoirs such as sinks, floors, baths, soap-
dishes and dishcloths. Pseudomonas aeruginosa is
considered an opportunistic pathogen as it causes
hospital-acquired infection, particularly in immu-
nocompromised hosts, burn victims or in those with
faulty homeostasis mechanisms or metabolic dis-
orders [1–3].
Pseudomonas aeruginosa can be internally divid-
ed into subgroups by classical methods such as bio-
typing, serotyping, pyocin typing and phage typing.
However, the discriminatory power is much lower
than that obtained by molecular typing methods.
DNA typing methods have been frequently used for
investigating the diversity of collections of
Pseudomonas aeruginosa [4]. These methods include
pulsed-field gel electrophoresis (PFGE) [5, 6], ri-
botyping [7], restriction fragment length polymor-
phic DNA analysis (RFLP) [7], random amplified
polymorphic DNA assay (RAPD) [3, 5], arbitrary
primed PCR (AP-PCR) [3], amplified fragment
length polymorphism (AFLP) [5], and repetitive el-
ement based PCR (rep-PCR) [3, 6, 7].
Rep-PCR is a method for fingerprinting bacterial
genomes, which examines strain-specific patterns ob-
tained from PCR amplification of repetitive DNA
elements present within bacterial genomes. Three
main sets of repetitive elements are used for typing
purposes: the repetitive extragenic palindromic (REP)
sequence, the enterobacterial repetitive intergenic
consensus sequence (ERIC) and the BOX elements.
REP-PCR and ERIC-PCR have been shown to be
useful for typing Pseudomonas aeruginosa isolates [8].
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To our knowledge, the rep-PCR fingerprinting meth-
od using the BOX primer has never been tested on
Pseudomonas aeruginosa in Poland.
In this work, we used the BOX-PCR method for
the typing of clinical Pseudomonas aeruginosa isolates.
Material and methods
Bacterial strains. Sixty two strains of Pseudomonas aerugi-
nosa were originally isolated from a variety of clinical spec-
imens: feces (26); urine (12); blood (1); bronchial washings
(8); sputum (1); wound swab (9); throat swab (2; ulceration
swab (1); swab from skin around tracheotomy (1); and from
ear (1). The bacteria were obtained from 62 patients from
different wards of the Municipal Hospital, Main Hospital
and the outpatients’ department in Siedlce (Poland), be-
tween December 2005 and March 2006. The strains were
identified as Pseudomonas aeruginosa according to biochem-
ical patterns in the Api 20NE system (bio Mérieux). The
control strain NCTC 6749 was also examined. Stock cul-
tures were stored in TSB (tripticase soy broth, Difco) con-
taining 20% glycerol at –80°C.
DNA extraction. Isolates were grown in TSB at 37°C for
24 h and DNA was extracted using the Genomic DNA Pre
Plus (A&A Biotechnology, Gdansk, Poland).
BOX-PCR typing. BOX-PCR fingerprinting was carried out
using one primer of sequence 5'-CTACGGCAAGGC-
GACGCTGACG-3'. Amplification was carried out with
a 10 × PCR buffer (100 mM Tris-HCl, 1 mM DTT, 0.1 mM
EDTA, 100 mM KCl, 0.5% Nonidet P40, 0.5% Tween 20)
in a total reaction of 50 μl containing 2.5 mM dNTP, 20 mM
MgCl2, 100 pmol of primer, 2 μl of genomic template DNA,
and 1 unit of Taq DNA polymerase (DNA Gdansk, Poland).
BOX-PCR typing was carried out according to Dawson et
al. [7] using a PTC-100 Programmable Thermo Controller
(MJ Research) according to the following procedure: ini-
tial denaturation at 94°C for 5 min followed by 35 cycles of
PCR consisting of denaturation at 94°C for 1 min, anneal-
ing at 48°C for 2 min, and extension at 72°C for 2 min; in the
last cycle, the extension time was 5 min. The PCR product
(10 μl) was analyzed using a 2% agarose gel in the TBE
buffer (5.4 g l–1 Tris, 2.75 g l–1 Boric acid, 0.37 g l–1 EDTA
(pH 8.0)) and photographed under a UV light. The size of
the products was analyzed using a M100–1000 bp ladder
MW size marker (DNA Gdansk, Poland).
Results and discussion
Various molecular techniques have been developed
for typing strains of Pseudomonas aeruginosa [3, 5–7].
Pulse field gel electrophoresis (PFGE) is recognized
as the gold standard typing method for Pseudomonas
aeruginosa. However, it is labor intensive and limited
by high cost and extended turnaround time [5, 6, 8]. In
contrast to PFGE, the highly specific rep-PCR tech-
nique is an easy procedure, requiring little time for
results, and is characterized by low labor costs [6–8].
Rep-PCR with primers based on REP and ERIC se-
quences has been successfully used to differentiate
strains of Bartonella spp., Bacillus subtilis, Citrobacter
diversus, Enterobacter aerogenes, Salmonella enterica
Typhi, methicillin-resistant Staphylococcus aureus,
Streptococcus pneumoniae, Acinetobacter baumanii,
Burkholderia cepacia, Burkholderia pseudomallei,
Pseudomonas aeruginosa, Legionella pneumophilia,
Helicobacter pylori, Neisseria gonorrhoeae and Neisser-
ia meningitidis. While REP and ERIC sequences are
the most commonly used targets for DNA typing, an-
other repetitive element, the BOX sequence, has been
used to differentiate Streptococcus pneumoniae [8].
Recently, the BOX-PCR method was used for typing
strains of different genera of Pseudomonas (Pseudomo-
nas aeruginosa, Pseudomonas syringae, Pseudomonas
putida and Pseudomonas fluorescens) [6, 7, 9–11].
In the present study, the BOX primer sequence was
used in PCR to detect differences in the number and
distribution of this bacterial repetitive sequence in the
clinical isolates Pseudomonas aeruginosa genomes.
BOX-PCR fingerprinting revealed 38 genetic patterns,
among them seven main genotypes, containing three
to eight isolates and 30 other unique patterns. The clus-
ters were shown in two to 11 bands between 280–1,550
bp. More than half of the isolates had five to eight bands
per pattern. The most characteristic products of PCR
for Pseudomonas aeruginosa were the following: 200,
420, 650, 1,200 and 1,400 bp (Figure 1).
Two of the genotypes (8 and 21) consisted of sev-
en (11.3%) and eight (12.9%) isolates, respectively.
The next two most numerous genotypes (4 and 13)
contained four (6.45%) isolates. All these isolates
were obtained from the feces of patients hospitalized
in the Main and Municipal Hospitals. Because the
incidence of the same genetic types of Pseudomonas
aeruginosa isolated from feces occurred in two differ-
ent hospitals, it was possible to postulate that the same
clone was present in the environments of both hospi-
tals. The remaining three numerous genotypes
(11, 23 and 5), respectively, consisted of isolates from
wound (3 isolates), bronchial washings (3), urine (2),
and wound (1) patients being treated at the Main
Hospital. Other unique types were collected from the
following clinical specimens: urine (83.3%), wound
(55.5%), bronchial washings (62.5%), feces (11.5%)
and sputum (1), throat swab (2), ulceration swab (1),
swab from skin around tracheotomy (1), blood (1) and
from ear (1). This data demonstrated that isolates from
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urine, wound and bronchial washings were highly het-
erogeneous; among 12, nine and eight isolates, 11, sev-
en and six respectively different clusters appeared,
while the group of isolates from feces showed slight
genetic variations. In the group of 26 isolates, we de-
tected seven genotypes (Table 1).
Similar results were obtained using the ERIC-PCR
method for typing the same Pseudomonas aeruginosa
isolates; 11 major clonal groups and 25 unique geno-
types [12]. This result is in agreement with the stud-
ies of Syrmis et al. [6], in which the ERIC-PCR and
BOX-PCR methods have the same discriminatory
power. These authors showed six major clonal groups,
and 58 distinct clonal groups among 163 Pseudomo-
nas aeruginosa strains isolated from patients with cys-
tic fibrosis. Morrelli et al. [11] by the BOX-PCR meth-
Figure 1. BOX-PCR fingerprinting of Pseudomonas aeruginosa strains. The lane M is a molecular weight marker
(MW100–1000 bp, DNA-Gdansk, Poland)
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Table 1. Compilation of BOX-PCR data for clinical Pseudomonas aeruginosa isolates
No. of BOX-PCR Source Hospital/ No. of BOX-PCR Source Hospital/
isolates genotype  of isolation /ward*  isolates  genotype  of isolation /ward*
1 1 Urine Main/1 33 5 Urine Main/6
2 2 Urine Main/2 34 23 Bronchial washings Main/5
3 3 Wound Main/3 35 24 Bronchial washings Main/7
4 4 Feces Municipal/4 36 21 Feces Municipal/4
5 4 Feces Municipal/4 37 21 Feces Main/8
6 5 Urine Main/5 38 21 Feces Municipal/4
7 6 Urine Main/6 39 25 Bronchial washings Main/10
8 4 Feces Municipal/4 40 5 Wound Main/3
9 7 Sputum Main/7 41 21 Feces Municipal/4
10 8 Feces Main/8 42 26 Throat swab Main/7
11 8 Feces Municipal/4 43 8 Feces Main/8
12 4 Feces Main/8 44 27 Urine Outpatients’
department
13 8 Feces Municipal/4 45 8 Feces Municipal/4
14 8 Feces Municipal/4 46 28 Wound Main/9
15 9 NCTC6749 – 47 21 Feces Municipal/4
16 10 Wound Municipal/9 48 23 Bronchial washings Main/10
17 11 Wound Main/3 49 29 Urine Main/11
18 11 Wound Main/2 50 21 Feces Municipal/4
19 12 Bronchial Main/7 51 23 Bronchial washings Main/10
washings
20 13 Feces Municipal/4 52 21 Feces Municipal/4
21 13 Feces Municipal/4 53 30 Feces Main/8
22 13 Feces Municipal/4 54 31 Ulceration Municipal/9
23 14 Throat swab Main/7 55 11 Wound Main/2
24 15 Skin Main/7 56 32 Bronchial washings Main/7
25 13 Feces Main/8 57 33 Urine Main/8
26 16 Feces Main/8 58 8 Feces Main/8
27 17 Wound Main/2 59 34 Feces Main/8
28 18 Bronchial Main/7 60 35 Blood Main/12
washings
29 19 Wound Main/9 61 36 Bronchial washings Main/7
30 20 Urine Outpatients’ 62 37 Urine Outpatients’
department department
31 21 Feces Municipal/4 63 38 Ear Outpatients’
department
32 22 Urine Outpatients’
department
1. Obstetric-gynecological ward; 2. Orthopedic trauma ward; 3. Orthopedic ward; 4. Infectious ward; 5. Urological ward; 6. Rehabilitation ward;
7. Intensive care unit (ICU); 8. Pediatric ward; 9. Surgical ward; 10. Neurological ward; 11. Pathology of pregnancy ward; 12. Oncology ward
od found 179 genotypes in 340 Pseudomonas aerugi-
nosa isolates from CF patients. Liu et al. [3], using
the ERIC-PCR method, indicated that the 47 isolates
of Pseudomonas aeruginosa that had caused bactere-
mia in 19 cancer patients were indistinguishable.
17 other isolates that had caused bacteremia in ten
cancer patients were discriminated into eight further
groups. The 24 environmental and non-cancer patient
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isolates were grouped into further distinct groups. In
contrast, Dawson et al. [7] demonstrated the consid-
erable homogeneity of Pseudomonas aeruginosa iso-
lates and, conversely, the heterogeneity within the
other species, in particular Pseudomonas putida and
Pseudomonas fluorescens.
The results of this study demonstrated that BOX-
-PCR is a rapid and highly discriminatory and repro-
ducible assay which proved to be a powerful surveil-
lance tool for typing Pseudomonas aeruginosa isolates.
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